Randomized phase II trial of panitumumab (P), erlotinib (E), and gemcitabine (G) versus erlotinib-gemcitabine in patients with untreated, metastatic pancreatic adenocarcinoma
- Citation:
- J Clin Oncol vol 29 (suppl 4) abstr 238
- Meeting Instance:
- ASCO 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2747
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- G. P. Kim N. R. Foster M. Salim P. J. Flynn D. F. Moore Jr R. Zon R. B. Mowat M. Wiesenfeld A. E. Mccullough S. R. Alberts
- Networks:
- Study
- NCCTG-N064B
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: